Literature DB >> 20829113

CD56 negative NK cells: origin, function, and role in chronic viral disease.

Niklas K Björkström1, Hans-Gustaf Ljunggren, Johan K Sandberg.   

Abstract

Natural killer (NK) cells serve as a first line of defense against acute viral infections. Immunogenetic association data suggest that NK cells also influence the course of chronic viral infections, such as infections with HIV-1 and hepatitis C virus (HCV). Chronic stages of these infections have a negative impact on NK cell function and promote the appearance of phenotypically and functionally abnormal NK cells. In this paper, we summarize available data on CD56(neg) NK cells, an aberrant NK cell subset found in small numbers in healthy individuals and at elevated levels in individuals chronically infected with HIV-1 and HCV. We discuss current knowledge of CD56(neg) NK cells, with a particular emphasis on their accumulation during chronic infection and the possible consequences of this for the host.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20829113     DOI: 10.1016/j.it.2010.08.003

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  96 in total

1.  Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model.

Authors:  Melissa A Geller; David A Knorr; David A Hermanson; Lee Pribyl; Laura Bendzick; Valarie McCullar; Jeffrey S Miller; Dan S Kaufman
Journal:  Cytotherapy       Date:  2013-10       Impact factor: 5.414

2.  CD56bright NK IL-7Rα expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections.

Authors:  Chelsey J Judge; Lenche Kostadinova; Kenneth E Sherman; Adeel A Butt; Yngve Falck-Ytter; Nicholas T Funderburg; Alan L Landay; Michael M Lederman; Scott F Sieg; Johan K Sandberg; Donald D Anthony
Journal:  J Leukoc Biol       Date:  2017-04-11       Impact factor: 4.962

3.  CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis.

Authors:  Liang Wang; Zhao Wang; Zhong-Jun Xia; Yue Lu; Hui-Qiang Huang; Yu-Jing Zhang
Journal:  Tumour Biol       Date:  2015-05-03

4.  High frequencies of polyfunctional CD8+ NK cells in chronic HIV-1 infection are associated with slower disease progression.

Authors:  Fareed Ahmad; Henoch S Hong; Marc Jäckel; Alexandra Jablonka; I-Na Lu; Nupur Bhatnagar; Johanna M Eberhard; Benjamin A Bollmann; Matthias Ballmaier; Margot Zielinska-Skowronek; Reinhold E Schmidt; Dirk Meyer-Olson
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

5.  Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival.

Authors:  Matthew Alderdice; Philip D Dunne; Aidan J Cole; Paul G O'Reilly; Darragh G McArt; Vicky Bingham; Marc-Aurel Fuchs; Stephen McQuaid; Maurice B Loughrey; Graeme I Murray; Leslie M Samuel; Mark Lawler; Richard H Wilson; Manuel Salto-Tellez; Vicky M Coyle
Journal:  Mod Pathol       Date:  2017-06-16       Impact factor: 7.842

6.  Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis.

Authors:  Madison R Mack; Jonathan R Brestoff; Melissa M Berrien-Elliott; Anna M Trier; Ting-Lin B Yang; Matthew McCullen; Patrick L Collins; Haixia Niu; Nancy D Bodet; Julia A Wagner; Eugene Park; Amy Z Xu; Fang Wang; Rebecca Chibnall; M Laurin Council; Carrie Heffington; Friederike Kreisel; David J Margolis; David Sheinbein; Paola Lovato; Eric Vivier; Marina Cella; Marco Colonna; Wayne M Yokoyama; Eugene M Oltz; Todd A Fehniger; Brian S Kim
Journal:  Sci Transl Med       Date:  2020-02-26       Impact factor: 17.956

7.  Diversity of peripheral blood human NK cells identified by single-cell RNA sequencing.

Authors:  Samantha L Smith; Philippa R Kennedy; Kevin B Stacey; Jonathan D Worboys; Annie Yarwood; Seungmae Seo; Everardo Hegewisch Solloa; Brandon Mistretta; Sujash S Chatterjee; Preethi Gunaratne; Kimaada Allette; Ying-Chih Wang; Melissa Laird Smith; Robert Sebra; Emily M Mace; Amir Horowitz; Wendy Thomson; Paul Martin; Steve Eyre; Daniel M Davis
Journal:  Blood Adv       Date:  2020-04-14

8.  Increased frequency and function of KIR2DL1-3⁺ NK cells in primary HIV-1 infection are determined by HLA-C group haplotypes.

Authors:  Christian Körner; Mitchell E Granoff; Molly A Amero; Michael N Sirignano; Sagar A Vaidya; Stephanie Jost; Todd M Allen; Eric S Rosenberg; Marcus Altfeld
Journal:  Eur J Immunol       Date:  2014-08-12       Impact factor: 5.532

9.  NK cells and CD1d-restricted NKT cells respond in different ways with divergent kinetics to IL-2 treatment in primary HIV-1 infection.

Authors:  C Kuylenstierna; J E Snyder-Cappione; C P Loo; B R Long; V D Gonzalez; J Michaëlsson; M Moll; G Spotts; F M Hecht; D F Nixon; J K Sandberg
Journal:  Scand J Immunol       Date:  2011-02       Impact factor: 3.487

10.  Identification of NK Cell Subpopulations That Differentiate HIV-Infected Subject Cohorts with Diverse Levels of Virus Control.

Authors:  Christopher W Pohlmeyer; Veronica D Gonzalez; Alivelu Irrinki; Ricardo N Ramirez; Li Li; Andrew Mulato; Jeffrey P Murry; Aaron Arvey; Rebecca Hoh; Steven G Deeks; George Kukolj; Tomas Cihlar; Stefan Pflanz; Garry P Nolan; Gundula Min-Oo
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.